Titan Medical Inc. (TSX:TMD)
Canada
· Delayed Price · Currency is CAD | Market Cap | 5.13M |
| Revenue (ttm) | 615.89K |
| Net Income (ttm) | -7.67M |
| Shares Out | 4.56M |
| EPS (ttm) | -1.84 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,688 |
| Average Volume | 2,008 |
| Open | 1.125 |
| Previous Close | 1.125 |
| Day's Range | 1.125 - 1.200 |
| 52-Week Range | 0.045 - 1.250 |
| Beta | 1.98 |
| RSI | 48.30 |
| Earnings Date | Nov 11, 2024 |
About Titan Medical
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view i... [Read more]
News
Titan Medical reports Q2 results
Titan Medical Provides Bi-Weekly MCTO Status Update
TORONTO, Ontario, May 15, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative informat...
Titan Medical Announces Receipt of MCTO
TORONTO, ON, April 04, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) announces that it has been granted a management cease trade order (“MCTO”) by the O...
Titan Medical Provides Corporate Update
TORONTO, ON, April 03, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) today provided an update on its annual filings and certain other corporate and oper...
Titan Medical Announces Delays in its Annual Filings and Planned Deregistration with the SEC
TORONTO, ON, March 22, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) today announces that, as a result of certain financial and operational challenges t...
Titan Medical Announces Decision of Nasdaq Hearings Panel to Delist Common Shares
Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade on the OTC Markets Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade...
Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements
Toronto, Ontario, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced senior leadership changes and the receipt of a notification f...
Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week
TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...
Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative surg...
Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery
TORONTO, ON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologie...
Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that in vi...
Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process
TORONTO, ON, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced...
Titan Medical Announces Commencement of Strategic Review Process
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (“Titan” or the “Company”), a medical technology company focused on single access robotic-assisted surgery (RAS),...
Titan Medical Announces American Association of Gynecologic Laparoscopy Global Congress Participation
TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced its attend...
Titan Medical Inc. (TMDI) Q3 2022 Earnings Call Transcript
Titan Medical Inc. (NASDAQ:TMDI) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Kristen Galfetti - VP of IR Cary Vance - President & CEO Stephen Lemieux - CFO Conf...
Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder Meeting
Shareholder Meeting to Support Share Consolidation to Maintain Nasdaq Listing Shareholder Meeting to Support Share Consolidation to Maintain Nasdaq Listing
Titan Medical to Issue Third Quarter 2022 Financial Results on November 10, 2022
Webcast to Follow Announcement Webcast to Follow Announcement
Titan Medical Announces Appointment of Eric Heinz as Vice President, Market and Corporate Development
TORONTO, ON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologi...
Titan Medical Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery
Strengthens company's intellectual property portfolio with innovations in next generation single access RAS technology Strengthens company's intellectual property portfolio with innovations in next ge...
Titan Medical Signs Definitive Agreement with Medtronic
Titan to support Medtronic development and pre-clinical activities through supply of instruments and cameras Titan to support Medtronic development and pre-clinical activities through supply of instru...
Titan Medical to Present at the H.C. Wainwright Global Investment Conference
TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced th...
Titan Medical Inc. (TMDI) CEO Cary Vance on Q2 2022 Results - Earnings Call Transcript
Titan Medical Inc. (NASDAQ:TMDI) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Kristen Galfetti - Vice President of Investor Relations Cary Vance - President & Chie...
Titan Medical Reports Financial Results for the Second Quarter 2022
New CEO Appointed, Manufacturing Progress Noted New CEO Appointed, Manufacturing Progress Noted
Titan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022
Webcast to Follow Announcement Webcast to Follow Announcement
Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer
TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...